RxDoctor Payments Data

Beth Ann Bremer

Family · Lexington, SCNPI 1205380185

Payments from drug & device makers

$1,799in general payments, 2019–2025

Across 81 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$350
  • Globus Medical$275
  • Novo Nordisk$196
  • Baxter Healthcare$193
  • AbbVie$165
  • Lilly USA, LLC$86
  • plus $535 from 17 others

What the payments were for

  • Travel & lodging$181%
  • Food & beverage$1,58888%
  • Other$19311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,799 in reported general payments places this provider in the 75th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$52,626
Medicare patients
243
Services billed
1,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$19,805
JanuviaSitagliptin Phosphate11$8,071
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,253
Albuterol Sulfate HfaAlbuterol Sulfate49$1,192
Rosuvastatin Calcium51$1,067
Atorvastatin Calcium55$1,009
Omeprazole51$750
Levothyroxine Sodium62$557
Pantoprazole Sodium31$505
Glimepiride15$477
Pravastatin Sodium52$473
Metoprolol Succinate24$404
Fenofibrate14$379
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav51$364
Fluticasone Propionate35$352

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$52$19,80519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,248 family providers in South Carolina.

Other family in Lexington

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →